| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |